BROOKLYN IMMUNOTHERAPEUTICS's ticker is BTX and the CUSIP is 114082100. A total of 39 filers reported holding BROOKLYN IMMUNOTHERAPEUTICS in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $23,000 | -52.1% | 91,997 | 0.0% | 0.00% | – |
| Q2 2022 | $48,000 | -95.6% | 91,997 | -82.7% | 0.00% | – |
| Q1 2022 | $1,092,000 | -48.6% | 532,691 | +4.6% | 0.00% | – |
| Q4 2021 | $2,124,000 | -54.3% | 509,258 | +1.9% | 0.00% | – |
| Q3 2021 | $4,649,000 | -41.2% | 499,860 | +13.8% | 0.00% | – |
| Q2 2021 | $7,908,000 | – | 439,095 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| AJ WEALTH STRATEGIES, LLC | 36,001 | $0 | 0.00% |